Insider Transactions in Q3 2023 at Bridge Bio Pharma, Inc. (BBIO)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 05
2023
|
Randal W. Scott |
SELL
Open market or private sale
|
Indirect |
2,500
-15.63%
|
$75,000
$30.0 P/Share
|
|
Aug 17
2023
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
51,552
-1.06%
|
$1,443,456
$28.59 P/Share
|
|
Aug 17
2023
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Open market or private sale
|
Direct |
22,683
-38.19%
|
$635,124
$28.59 P/Share
|
|
Aug 16
2023
|
Neil Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
50,698
-1.03%
|
$1,470,242
$29.8 P/Share
|
|
Aug 16
2023
|
Neil Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
102,250
+2.04%
|
-
|
|
Aug 16
2023
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
22,311
-27.31%
|
$647,019
$29.8 P/Share
|
|
Aug 16
2023
|
Brian C Stephenson Secretary, Treasurer & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
44,994
+35.51%
|
-
|
|
Aug 16
2023
|
Charles J Homcy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,301
-0.11%
|
$37,729
$29.8 P/Share
|
|
Aug 16
2023
|
Charles J Homcy |
BUY
Exercise of conversion of derivative security
|
Direct |
3,760
+0.31%
|
-
|
|
Jul 18
2023
|
Viking Global Investors LP |
SELL
Open market or private sale
|
Indirect |
1,500,000
-5.63%
|
$52,500,000
$35.0 P/Share
|